Get started
Author

Xenofon Baraliakos

Observed name: Baraliakos, Xenofon
ORCID: 0000-0002-9475-9362
Observed ORCID: 0000-0002-9475-9362
OpenAlex ID: A5100086270
High Frequency of Osteophytes Detected by High-Resolution Ultrasound at the Finger Joints of Asymptomatic Factory Workers
2023 · Mario Giulini, Ralph Brinks, et al. · Journal of Personalized Medicine · 2
PDF
Bimekizumab in Chinese patients with active radiographic axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE 2 study
2026 · Jieruo Gu, Liangjing Lu, et al. · Chinese Medical Journal · 1
Diffuse Idiopathic Skeletal Hyperostosis: The Evolution of a Disease Concept
2026 · Nikolaos Kougkas, George E. Fragoulis, et al. · Rheumatology and Therapy
Bimekizumab-Treated Patients with Axial Spondyloarthritis Maintained Stringent Clinical Responses Over 3 Years: Phase 3 and Open-Label Extension Results
2026 · Fabian Proft, Sergio Schwartzman, et al. · The Journal of Rheumatology
PDF
Bimekizumab in Chinese Patients with Active Non‑Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study
2026 · Adis journals on behalf of, Jieruo Gu, et al. · Figshare
Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study
2026 · Jieruo Gu, Liangjing Lu, et al. · Rheumatology and Therapy
PDF
Associations Between Clinical Characteristics and Magnetic Resonance Imaging of the Sacroiliac Joints and Spine: Exploratory Analysis of the Phase 4, Randomized, Placebo-Controlled STAR Study
2026 · Xenofon Baraliakos, Paul Bird, et al. · Journal of Psoriasis and Psoriatic Arthritis
Impact of bimekizumab on CANDEN spinal MRI inflammation and structural lesions in radiographic axial spondyloarthritis: 2-year phase 3 results
2026 · Walter P Maksymowych, Robert G W Lambert, et al. · Rheumatology
Title Fatherhood intentions among patients living with immune-mediated rheumatic musculoskeletal diseases (IM-RMDs): a scoping review
2026 · Omar-Javier Calixto, Diana Vossen, et al. · OSF Preprints (OSF Preprints)
Untitled
2026 · Christoph Fiehn, Ralph Gaulke, et al. · Arthritis und Rheuma
Praxisrelevante Fortbildung mit wissenschaftlichem Anspruch
2026 · Christoph Fiehn, Ralph Gaulke, et al. · Arthritis und Rheuma
Correction: Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA register (Arthritis research & therapy (2025) 27 1 PII: 114 DOI: 10.1186/s13075-025-03650-4.)
2026 · Lindner, Lisa, Weiss, Anja, et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Ixekizumab and Concomitant Tirzepatide Achieved Early Disease Control in Adults with Psoriatic Arthritis and Obesity/Overweight: Phase 3b TOGETHER-PsA Trial
2026 · Laura C Coates, Philip Mease, et al.
PDF
Ein herzliches Dankeschön
2025 · Xenofon Baraliakos, Christoph Fiehn, et al. · Arthritis und Rheuma
PDF
EULAR Congress Interview: Xenofon Baraliakos
2024 · Xenofon Baraliakos · EMJ Rheumatology
Works count: 57
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type